. Neural network dysfunction in Alzheimer's disease: a drug development perspective. Drug News Perspect. 2007 Nov;20(9):557-63. PubMed.

Recommends

Please login to recommend the paper.

Comments

  1. The idea is sound, but neuritic dystrophy means that there is a tauopathy.

    For Aβ oligomers that would interfere with LTP, because amyloid deposits are numerous before any significant cognitive impairment, why don't we observe LTP-related defects? Or are Abeta oligomers really toxic in the human brain?

Make a Comment

To make a comment you must login or register.